Brussels, 16/12/2005 (Agence Europe) - To encourage small and medium-sized enterprises (SMEs) to submit applications to the European Medicines Agency (EMEA), the European Commission has adopted significant fee reductions and deferrals for a number of EMEA services, such as scientific advice today. Other provisions relate to administrative assistance, in particular regarding translations, and to the establishment of a dedicated SME Office within the EMEA, providing a 'one-stop shop' for SMEs....